A plethora of clinical studies have shown that elevated circulating levels of the phosphaturic fibroblast growth factor 23 (FGF23) are associated with left ventricular hypertrophy (LVH), atrial fibrillation, systolic and diastolic dysfunction, as well as heart failure2–5. Here, FGF23 is linked to left ventricular hypertrophy.